Amwell (AMWL) announced Dan Zamansky as the company’s new chief product and technology officer, effective today. Zamansky will lead the company’s product and R&D organizations. He will focus on the comprehensive technology-enabled care platform Amwell offers payers and health systems to provide individuals with better access to more convenient, affordable and effective care. In addition, as more people seek care online and more clinical programs are available, Zamansky will ensure the Amwell platform continues to evolve and provide clients with an integrated future-ready solution.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMWL:
- Amwell reports grants to new employees under inducement plan
- Amwell price target raised to $12 from $10 at Truist
- Amwell’s Earnings Call: Strategic Growth Amid Challenges
- Amwell price target raised to $10 from $9 at Stifel
- Strong Revenue Performance and Strategic Growth: Justifying the Buy Rating for American Well